Suchergebnisse - "Cervantes, A"

PubPharm (249)

21

Impact of tumor heregulin mRNA expression on outcome of patients with advanced/metastatic squamous NSCLC treated with lumretuzumab, a glycoengineered monoclonal antibody targeting HER3, in combination with erlotinib

enthalten in: Annals of oncology | 2016

von Meulendijks, D. | Lassen, U. | Cervantes, A. | +17

22

A phase Ib study of lumretuzumab, a glycoengineered monoclonal antibody targeting HER3, in combination with carboplatin and paclitaxel as 1st-line treatment in patients with squamous non-small cell lung cancer

enthalten in: Annals of oncology | 2016

von Cejalvo, J. | Fleitas, T. | Felip, E. | +13

23

KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial

enthalten in: Annals of oncology | 2016

von Sclafani, F. | Chau, I. | Cunningham, D. | +17

24

441O Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC

enthalten in: Annals of oncology | 2016

von Ma, B. | Rudin, C. | Cervantes, A. | +11

25

Heterogeneity of driver genes and therapeutic implications in colorectal cancer

enthalten in: Annals of oncology | 2015

von Dienstmann, R. | Cervantes, A.

26

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial

enthalten in: Annals of oncology | 2015

von Sclafani, F. | Chau, I. | Cunningham, D. | +16

27

Adjuvant chemotherapy for rectal cancer after preoperative radiation or chemoradiation: one size does not fit all

enthalten in: Annals of oncology | 2015

von Cervantes, A. | Glynne-Jones, R.

28

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

enthalten in: The British journal of cancer | 2015

von Macarulla, T. | Cervantes, A. | Tabernero, J. | +10

29

Bayesian mixed treatment comparison of early treatment for Parkinson disease: an indirect comparison

enthalten in: Value in health | 2015

von Marquez, M. | Diaz, J. | Ibarra, A. | +4

30

Cost Effectiveness of Early Treatment of Parkinson’s Disease in Mexico

enthalten in: Value in health | 2015

von Marquez, M. | Diaz, J. | Pizarro, M. | +4